Jing P - Search Results

1

Clinical application of targeted next-generation sequencing utilizing bronchoalveolar lavage fluid in thoracic surgery ICU patients with suspected pulmonary infections.

Guo X, Xie N, Xi X, Li P, Jia J, Chen L, Ren M, Wang Y, Zhang P, Deng W, Wang Y, Jing P, Ding R, Gu Z. Guo X, et al. Among authors: jing p. J Appl Microbiol. 2025 Jan 6;136(1):lxae313. doi: 10.1093/jambio/lxae313. J Appl Microbiol. 2025. PMID: 39741395

2

Knockdown of MALAT1 expression inhibits HUVEC proliferation by upregulation of miR-320a and downregulation of FOXM1 expression.

Sun JY, Zhao ZW, Li WM, Yang G, Jing PY, Li P, Dang HZ, Chen Z, Zhou YA, Li XF. Sun JY, et al. Among authors: jing py. Oncotarget. 2017 Jun 16;8(37):61499-61509. doi: 10.18632/oncotarget.18507. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977880 Free PMC article.

3

Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.

Jing P, Zhao N, Ye M, Zhang Y, Zhang Z, Sun J, Wang Z, Zhang J, Gu Z. Jing P, et al. Cancer Lett. 2018 Jul 28;427:38-48. doi: 10.1016/j.canlet.2018.04.019. Epub 2018 Apr 19. Cancer Lett. 2018. PMID: 29679612 Free article.

4

miR-24-3p/FGFR3 Signaling as a Novel Axis Is Involved in Epithelial-Mesenchymal Transition and Regulates Lung Adenocarcinoma Progression.

Jing P, Zhao N, Xie N, Ye M, Zhang Y, Zhang Z, Li M, Lai X, Zhang J, Gu Z. Jing P, et al. J Immunol Res. 2018 Apr 5;2018:2834109. doi: 10.1155/2018/2834109. eCollection 2018. J Immunol Res. 2018. PMID: 29850625 Free PMC article.

5

The methylation induced by protein arginine methyltransferase 5 promotes tumorigenesis and progression of lung cancer.

Jing P, Xie N, Zhu X, Dang H, Gu Z. Jing P, et al. J Thorac Dis. 2018 Dec;10(12):7014-7019. doi: 10.21037/jtd.2018.10.100. J Thorac Dis. 2018. PMID: 30746248 Free PMC article. Review.

6

miR-24-3p/KLF8 Signaling Axis Contributes to LUAD Metastasis by Regulating EMT.

Jing P, Xie N, Zhao N, Zhu X, Li P, Gao G, Dang H, Gu Z. Jing P, et al. J Immunol Res. 2020 Apr 28;2020:4036047. doi: 10.1155/2020/4036047. eCollection 2020. J Immunol Res. 2020. PMID: 32411796 Free PMC article.

7

The human microbiome: A promising target for lung cancer treatment.

Sun Y, Wen M, Liu Y, Wang Y, Jing P, Gu Z, Jiang T, Wang W. Sun Y, et al. Among authors: jing p. Front Immunol. 2023 Jan 30;14:1091165. doi: 10.3389/fimmu.2023.1091165. eCollection 2023. Front Immunol. 2023. PMID: 36817461 Free PMC article. Review.

8

Evaluation of an ex vivo fibrogenesis model using human lung slices prepared from small tissues.

Sun Y, Jing P, Gan H, Wang X, Zhu X, Fan J, Li H, Zhang Z, Lin JCJ, Gu Z. Sun Y, et al. Among authors: jing p. Eur J Med Res. 2023 Mar 30;28(1):143. doi: 10.1186/s40001-023-01104-8. Eur J Med Res. 2023. PMID: 36998092 Free PMC article.

9

The PRMT5 inhibitor C9 mitigates hypoxia-induced carboplatin resistance in lung cancer by inducing autophagy.

Fan J, Li H, Ruan Q, Zhu X, Jing P, Gu Z. Fan J, et al. Among authors: jing p. Cell Biol Int. 2023 Oct;47(10):1702-1715. doi: 10.1002/cbin.12066. Epub 2023 Jun 28. Cell Biol Int. 2023. PMID: 37381616

10

Application of the patient-reported outcome-based postoperative symptom management model in lung cancer: a multicenter randomized controlled trial protocol.

Liang Y, Jing P, Gu Z, Shang L, Ge P, Zhang Y, Wang L, Qiu C, Zhu X, Tan Z. Liang Y, et al. Among authors: jing p. Trials. 2024 Feb 17;25(1):130. doi: 10.1186/s13063-024-07963-8. Trials. 2024. PMID: 38365704 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

485 results

Search Page

Filters